GLAUCOMA MANAGEMENT

Powerful combination of Brimonidine tartarate0.15% & Timolol maleate 0.5%.
Powerful combination of selective alpha-2 agonist & nonselective beta-blocker.
A safe & efficacious treatment for elevated IOP for patients with Primary Open Angle Glaucoma & Ocular Hypertension.
Dual Mechanism of Action reduces aqueous production & enhance uveoscleral outflow.
Combination produces a significant greater lowering of IOP than monotherapy.


Powerful Combination in Effective IOP Control


Sterile aqueous vehicle
Contains, Timolol Maleate 0.5% w/v.
Proven potency & Efficacy.
Due to TimogoldTM, 62% of eyes achieved Target IOP.
Unmatched safety profile & always preferred for long term use.


Gold Standard in Glaucoma Therapy